Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly affecting extremely
preterm infants. Although mechanical ventilation and oxygen requirements in premature …

Background Systematic reviews showed that systemic postnatal corticosteroids reduce the
risk of bronchopulmonary dysplasia (BPD) in preterm infants. However, corticosteroids have …

Large Animal Internal Medicine, 4th Edition features a problem-based approach with
discussions of over 150 clinical signs. This is the first internal medicine reference that …

Procedural pain is associated with poorer neurodevelopment in infants born very preterm (⩽
32weeks gestational age), however, the etiology is unclear. Animal studies have …

The purpose of this revised statement is to review current information on the use of postnatal
glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to …

Background: Synthetic glucocorticoids are commonly used in reproductive medicine. Fetal
organ systems are highly sensitive to changes in the intrauterine environment, including …

Objective. There is much concern about potential neurodevelopmental impairment after
neonatal corticosteroid treatment for chronic lung disease. Dexamethasone is the …

BACKGROUND. Low cortisol concentrations in premature infants have been correlated with
increased severity of illness, hypotension, mortality, and development of bronchopulmonary …

OBJECTIVE. Postnatal steroid use decreases lung inflammation but increases impairment.
We hypothesized that increased dose is associated with increased neurodevelopmental …

Objectives To compare regional cerebral cortical microstructural organization between
preterm infants at term-equivalent age (TEA) and healthy full-term newborns, and to …